Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,018 total articles

Quest Diagnostics CEO's Stock Sale and Recent Company Developments

Quest Diagnostics CEO's Stock Sale and Recent Company Developments

J. E. Davis, the CEO and President of Quest Diagnostics Inc., completed a sale of company stock valued at approximately $1.94 million on June 1, 2026. This transaction occurred while the stock traded near $193.16. Beyond this executive action, the company has announced significant financial developments, including a quarterly cash dividend and a la…

Airgain CEO Sells Shares Amid Stock Valuation Debate

Airgain CEO Sells Shares Amid Stock Valuation Debate

Jacob Suen, President and CEO of Airgain Inc., sold a portion of his common stock on June 1, 2026. This transaction occurred while the stock was trading near its recent highs, raising discussion about the company's valuation relative to its strategic pivot toward mission-critical connectivity solutions.

Atmus Filtration SVP Sells Shares Amid Company Developments

Atmus Filtration SVP Sells Shares Amid Company Developments

Charles Masters, Senior Vice President of Atmus Filtration Technologies Inc., executed a sale of company stock totaling $130,763. This transaction occurred while the stock experienced volatility but was set against a backdrop of positive corporate news, including an earnings beat and a declared dividend. The firm also announced a key leadership app…

Regulatory Officer's Stock Transactions at Neurocrine Biosciences Provide Insight into Internal Activity

Regulatory Officer's Stock Transactions at Neurocrine Biosciences Provide Insight into Internal Activity

Chief Regulatory Officer Ingrid Delaet recently engaged in stock transactions involving Neurocrine Biosciences common stock. The filing details a sale valued at $354,321 and an acquisition of shares resulting from the exercise of non-qualified stock options. Separately, Neurocrine reported strong Q1 2026 financial results, exceeding expectations fo…

Extreme Networks Officer Sells Significant Stake in Company Stock

Extreme Networks Officer Sells Significant Stake in Company Stock

Katayoun Motiey, Chief Legal Admin Sust Officer at Extreme Networks Inc. (NASDAQ:EXTR), sold a total of 15,000 shares of the company's common stock worth $427,500 over two consecutive trading days in June 2026. These sales occurred while EXTR stock is near its 52-week high and following recent reports of strong financial performance and positive an…

Ameresco Director Sells Shares Following Options Exercise; Company Reports Major Infrastructure and JV Developments

Ameresco Director Sells Shares Following Options Exercise; Company Reports Major Infrastructure and JV Developments

A filing revealed that Ameresco director Francis V. Wisneski Jr. sold 5,000 shares of the company on May 29, 2026, for a total value of $180,600. This sale occurred after he acquired an equal number of shares through the exercise of stock options. These transactions take place against a backdrop of Ameresco's significant operational achievements, i…